Clinical Trial
doi: 10.1007/BF00262422.
Sequential chemotherapy and circadian rhythm in human solid tumours. A randomised trial
- PMID: 393429
- DOI: 10.1007/BF00262422
Item in Clipboard
Clinical Trial
Sequential chemotherapy and circadian rhythm in human solid tumours. A randomised trial
Cancer Chemother Pharmacol.
1979.
Abstract
Sixty-three patients were randomised into two groups each receiving the same 40-h sequential chemotherapy regimen (methotrexate or 5-FU, followed by vinblastine and cyclophosphamide). In the group receiving infusions of chemotherapeutic agents at times taking into account the circadian rhythm of tumoral proliferation, the antitumoral effectiveness appeared significantly better with respect to both tumoral regressions (85% contrasting with 58% in the other group) and the duration of response and survival.
Similar articles
-
Inclusion of vindesine in sequential chemotherapy based upon the circadian rhythm of human solid tumors.J Cancer Res Clin Oncol. 1979 Sep;95(1):99-100. doi: 10.1007/BF00411116. J Cancer Res Clin Oncol. 1979. PMID: 500773 Free PMC article. No abstract available.
-
[Sequential chemotherapy based on the hypothesis of a circadian rhythm of tumor proliferation].Nouv Presse Med. 1975 Nov 8;4(38):2709-12. Nouv Presse Med. 1975. PMID: 1105421 Clinical Trial. French.
-
[Sequential chemotherapy aimed at the synchronization-recruitment and circadian rhythm of solid tumors in the adult: theoretical bases and results of a randomised trial].Rev Med Liege. 1977 Oct 15;32(20):635-9. Rev Med Liege. 1977. PMID: 601371 Clinical Trial. French. No abstract available.
-
Chronomodulation of chemotherapy against metastatic colorectal cancer. International Organization for Cancer Chronotherapy.Eur J Cancer. 1995 Jul-Aug;31A(7-8):1264-70. doi: 10.1016/0959-8049(95)00242-b. Eur J Cancer. 1995. PMID: 7577034 Review.
-
[Chronochemotherapy for cancer].Gan To Kagaku Ryoho. 1997 Aug;24(10):1191-202. Gan To Kagaku Ryoho. 1997. PMID: 9279336 Review. Japanese.
Cited by
-
The Genomic Landscape and Pharmacogenomic Interactions of Clock Genes in Cancer Chronotherapy.Cell Syst. 2018 Mar 28;6(3):314-328.e2. doi: 10.1016/j.cels.2018.01.013. Epub 2018 Mar 7. Cell Syst. 2018. PMID: 29525205 Free PMC article.
-
Fundamental pharmacokinetic limits on the utility of using a sinusoidal drug delivery system to enhance therapy.J Pharmacokinet Biopharm. 1992 Oct;20(5):477-500. doi: 10.1007/BF01061467. J Pharmacokinet Biopharm. 1992. PMID: 1287198
-
Inclusion of vindesine in sequential chemotherapy based upon the circadian rhythm of human solid tumors.J Cancer Res Clin Oncol. 1979 Sep;95(1):99-100. doi: 10.1007/BF00411116. J Cancer Res Clin Oncol. 1979. PMID: 500773 Free PMC article. No abstract available.
-
Implications of Circadian Rhythm Regulation by microRNAs in Colorectal Cancer.Cancer Transl Med. 2016 Jan-Feb;2(1):1-6. doi: 10.4103/2395-3977.177555. Epub 2016 Feb 28. Cancer Transl Med. 2016. PMID: 27747302 Free PMC article.
-
Neurological toxicity of vindesine used in combination chemotherapy of 51 human solid tumors.Cancer Chemother Pharmacol. 1981;6(2):175-81. doi: 10.1007/BF00262339. Cancer Chemother Pharmacol. 1981. PMID: 7307235